CTLA4 and biliary tract cancer: In recent years, researchers have conducted in-depth studies on IRGs that lead to differences of immune infiltration in biliary tract cancers, and found that CTLA4 could affect chemotherapy resistance and prognosis through activation of Treg cells (39).